ABBV vs ALKT · P/E 81, rev $16.99B vs rev $256.0M
AbbVie Inc (ABBV) versus Alkami Technology Inc (ALKT) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
Alkami Technology Inc (ALKT) is a software - application company listed on US.
Latest reported ABBV revenue for 2026-06-30 was $16.99B. Net income was $3.61B. Revenue was up 13.3% from 2026-03-31 to 2026-06-30. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported ALKT revenue for 2026-06-30 was $256.0M. Net income was -$18.9M. Revenue was up 126.6% from 2025-09-30 to 2026-06-30. ALKT currently screens at market cap $1.82B.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. ALKT currently screens at market cap $1.82B.
Not investment advice. Open the ABBV and ALKT stock pages for the full models.
Not investment advice.